SPY368.16+1.47 0.40%
DIA301.20+1.14 0.38%
IXIC12,421.21+44.03 0.36%

Novus Therapeutics Q3 EPS $(5.51) Down From $(4.01) YoY

Novus Therapeutics (NASDAQ:NVUS) reported quarterly losses of $(5.51) per share. This is a 37.41 percent decrease over losses of $(4.01) per share from the same period last year.

· 11/16/2020 16:01
Novus Therapeutics (NASDAQ:NVUS) reported quarterly losses of $(5.51) per share. This is a 37.41 percent decrease over losses of $(4.01) per share from the same period last year.